Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer
Brauner, Eran, Gunda, Viswanath, Borre, Pierre Vanden, Zurakowski, David, Kim, Yon Seon, Dennett, Kate Virginia, Amin, Salma, Freeman, Gordon James, Parangi, SarehVolume:
7
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.7839
Date:
March, 2016
File:
PDF, 11.21 MB
english, 2016